Rev. bras. epidemiol. vol.17 número4
Texto
Imagem
Documentos relacionados
Objectives: To determine differences in overall survival and quality of life among patients with stage IV non-small cell lung cancer non-metastatic to the brain treated with
Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern
The aim of this study is to investigate whether there is a correlation between anemia, other clinic- pathological factors and survival in patients with advanced NSCLC treated
Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung
(2015) Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with
Other studies, using the monoclonal antibody 8F1[43] have reported that the presence of ERCC1 protein is a prognostic marker of survival in early NSCLC and a predictor of outcome
This study aimed at evaluating the ten-year survival and the prognostic factors for breast cancer in women treated at a referral center for cancer care in southeastern